Incyte Announces Positive CHMP Opinion for Zynyz® for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal 30 January
Incyte Announces Positive Topline Results from Pivotal Study of Tafasitamab as a First-line Treatment for Diffuse Large B-Cell Lymphoma 05 January
